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Abstract
OBJECTIVES: Cardioplegic myocardial protection is used in most cardiac surgical procedures. However, other alternatives have proved
useful. We analysed the perioperative results in a large series of patients undergoing coronary artery bypass (CABG) using cardiopulmonary
bypass (CPB) and non-cardioplegic methods.
METHODS: From January 1992 to October 2013, 8515 consecutive patients underwent isolated CABG with CPB without cardioplegia,
under hypothermic ventricular ﬁbrillation and/or an empty beating heart. The mean age was 61.9 ± 9.5 years, 12.4% were women, 26.3%
diabetic, 64% hypertensive; and 9.6% had peripheral vascular disease, 7.8% cerebrovascular disease and 54.3% previous acute myocardial
infarction (AMI). One-third of patients were in Canadian Cardiovascular Society Class III/IV. Three-vessel disease was present in 76.5% of
the cases and 10.9% had moderate/severe left ventricle (LV) dysfunction (ejection fraction <40%). A multivariate analysis was made of risk
factors associated to in-hospital mortality and three major morbidity complications [cerebrovascular accident, mediastinitis and acute
kidney injury (AKI)], as well as for prolonged hospital stay.
RESULTS: The mean CPB time was 58.2 ± 20.7 min. The mean number of grafts per patient was 2.7 ± 0.8 (arterial: 1.2 ± 0.5). The left internal
thoracic artery (ITA) was used in 99.4% of patients and both ITAs in 23.1%. The in-hospital mortality rate was 0.7% (61 patients), inotropic
support was required in 6.6% and mechanical support in 0.8, and 2.0% were re-explored for bleeding and 1.3% for sternal complications
(mediastinitis, 0.8%). AKI, the majority transient, occurred in 1595 patients (18.9%). The incidence rates of stroke/transient ischemic attack
(TIA) and acute myocardial infarction (AMI) were 2.6 and 2.5%, respectively, and atrial ﬁbrillation/ﬂutter occurred in 22.6% of cases. Age,
LV dysfunction, non-elective surgery, previous cardiac surgery, peripheral vascular disease and CPB time were independent risk factors for
mortality and major morbidity. The mean hospital stay was 7.2 ± 5.7 days.
CONCLUSIONS: Isolated CABG with CPB using non-cardioplegic methods proved very safe, with low mortality and morbidity. These
methods are simple and expeditious and remain as very useful alternative techniques of myocardial preservation.
Keywords: Coronary artery bypass grafting • Myocardial protection • Non-cardioplegic techniques • Hypothermic ventricular ﬁbrillation •
On-pump heart beating • Outcomes
INTRODUCTION
During the early years of myocardial revascularization (CABG),
various techniques were used for preservation of the myocardium.
Methods that involved ventricular ﬁbrillation with varying degrees
of hypothermia and either aortic or local vessel occlusion (or both)
were routinely used. But from the late 1970s, most surgeons have
started to turn to cardioplegic techniques.
The enthusiasm for cardioplegic methods has made many sur-
geons unaware of modiﬁcations made in the older techniques
that have resulted in continuously improved operative results. Still
today, a respectable minority of surgeons and institutions are
using or have returned to non-cardioplegic methods for myocar-
dial protection. We had routinely used cardioplegia during CABG
until the early 1990s. Since then, and after having assisted with a
demonstration in a foreign department, we started using intermit-
tent aortic cross-clamping, initially and moderate-hypothermic
ventricular ﬁbrillation, without clamping, in virtually all cases after
1992. This occurred after a preliminary comparative study of car-
dioplegia versus non-cardioplegia showed advantages of the
latter, in our hands [1].
In the current study, we aimed at evaluating the perioperative
results in a large cohort of patients undergoing isolated CABG
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with cardiopulmonary bypass (CPB) using non-cardioplegic
methods at a single centre during the last two decades.
MATERIALS ANDMETHODS
Population, study design and deﬁnitions
We have performed a retrospective study of patients undergoing
CABG under CPB from January 1992 to October 2013. Only patients
undergoing isolated ﬁrst operations and reoperations were in-
cluded. Patients undergoing off-pump surgery or who had CABG
combined with heart valve repair or replacement, resection of ven-
tricular aneurysm or other surgical procedures were excluded.
The records of 8515 consecutive patients were identiﬁed and
retrieved for analysis from our institutional prospective CABG regis-
try. This group represents 94.8% of all patients undergoing isolated
CABG during this time period (5.2% had incomplete records). Data
had been registered prospectively on a standardized written chart
by the involved surgeon and validated and inputted into a compu-
terized database by the ﬁrst author. Data collection and storage
were supervised by the project coordinator (Manuel J. Antunes) for
consistency, and aggregate outputs were periodically cross-checked
against an independent clinical database.
The study included the following preoperative, operative and
postoperative variables:
(i) Preoperative: age, body mass index, gender, hypertension,
recent smoking, peripheral vascular disease, cerebrovascular
disease, baseline serum creatinine, renal impairment, chronic
obstructive pulmonary disease, cardiomegaly, previous myo-
cardial infarction, recent myocardial infarction, unstable angina,
Canadian Cardiovascular Society (CCS) class, non-elective
surgery, previous percutaneous coronary intervention, previous
cardiac surgery, left ventricular ejection fraction, left ventricular
dysfunction, left main disease and extent of coronary disease
(one-, two- or three-vessel). Deﬁnitions of these variables are
presented in Table 1.
(ii) Operative: number and type of grafts, number of periods and
time of aortic cross-clamp, use of coronary endarterectomy
and CPB times.
(iii) Postoperative: In-hospital mortality and the following post-
operative morbidity complications: inotropic support, mechan-
ical support, cerebrovascular accident, mediastinitis, myocardial
infarction, acute kidney injury (AKI), respiratory failure, reopera-
tion for bleeding, atrial arrhythmias and length of hospital stay.
The deﬁnitions of these events are presented in Table 2.
All these variables were analysed as events occurring from the
date of the surgery to the date of discharge from the hospital, with
the exception of mortality and mediastinitis, which were analysed
as events occurring from surgery to discharge or after discharge,
within 30 days of the procedure.
AKI was deﬁned according to the consensus deﬁnitions estab-
lished by the Acute Kidney Injury Network [2] using serum creatin-
ine criteria. The highest serum creatinine level within 2 days
preceding the surgery was taken as the preoperative creatinine
level. Postoperative renal function was assessed using the serum
level of creatinine daily for the ﬁrst 3 days postoperatively, on
postoperative day 5, before discharge and whenever clinically
indicated. AKI was deﬁned according to the Acute Kidney Injury
Network criteria: increase of serum creatinine ≥0.3 mg/dl or
increase ≥150–200% from baseline. Creatinine clearance was cal-
culated using the Cockcroft–Gault formula.
Preoperative and operative data
The baseline characteristics of the population are detailed in
Table 3. The mean age was 61.9 ± 9.5 years, but 63.5 ± 9.6 years in
the last decade (range 23–85 years; 11.5% <50 years), and 12.4%
were female. More than a quarter (26.3%) of the patients were
diabetic, 64% were hypertensive, 9.6% had peripheral vascular
disease and 7.8% had cerebrovascular disease. A previous myocar-
dial infarction was recorded in 54.3% of the patients, 9.3% of
which had occurred within the 30 days preceding surgery. Renal
impairment was present to some degree in the majority (80.1%) of
patients, previous cardiac surgery had been performed in 1.3 and
33.4% were in CCS Class III/IV. Three-vessel disease was present in
76.5% of the cases, and 10.9% had moderate/severe left ventricu-
lar dysfunction (ejection fraction <40%). Emergency surgery was
performed in 4.3% of the cases. All other operations were per-
formed electively within a few days of referral (no waiting list).
Operative data are resumed in Table 3. The internal thoracic
artery (ITA), which was the only type of arterial graft used in this
population, was used in almost all patients (n = 8474; 99.5%). The
rate of use of left ITA, right ITA and bilateral ITA use was, respect-
ively, 99.4, 23.3 and 23.1%. Arterial grafts were used almost exclu-
sively for the territories of the left anterior descending and
circumﬂex arteries. The mean number of arterial anastomoses was
Table 1: Definition of preoperative variables
Hypertension Blood pressure exceeding 140/90 mmHg, or a
history of high blood pressure or the need
of antihypertensive medications
Recent smoking Up to less than 4 weeks of surgery
Cardiomegaly Cardiothoracic ratio >0.50 on a chest X-ray
film
Diabetes mellitus History of the disease and the patient
currently receiving treatment with either
oral medications or insulin
Anaemia Haematocrit ≤34%
Chronic pulmonary
disease
Patient requires pharmacological therapy for
the treatment of chronic pulmonary
compromise, or patient has a FEV1 <75% of
the predicted value
Cerebrovascular
disease
Unresponsive coma >24 h, CVA or TIA
Previous cardiac
surgery
Requiring opening of the pericardium
Recent myocardial
infarction
Myocardial infarction within 30 days
Unstable angina Rest angina requiring i.v. nitrates until arrival
in the anaesthetic room
Left ventricular
dysfunction
Ejection fraction <40%
Renal dysfunction Creatinine clearance <90 ml/min (classified
into three groups: MDRD1, 60–90 ml/min;
MDRD2 – 30–59 ml/min; MDRD3, <30 ml/
min)
Intra-aortic balloon
pump
Preoperative intra-aortic balloon pump for
haemodynamic reasons
Non-elective surgery Urgent or emergent surgery
CVA: cerebrovascular accident; MDRD: modification of diet in renal
disease; TIA: transient ischemic attack.
P.E. Antunes et al. / European Journal of Cardio-Thoracic Surgery2
1.2 per patient. In addition, a mean of 1.5 venous anastomoses
per patient were constructed. Hence, the average of the distal
anastomoses was 2.7 per patient. Coronary endarterectomy was
performed in 362 patients (4.3%), 313 (3.7%) to the right and 49
(0.6%) to the left coronary system.
Decision-making and procedures
In the last decade, decision-making and patient information in the
elective setting followed the lines now recommended in the ESC/
EJCTS guidelines on myocardial revascularization [3]. Institutional
protocols were developed to implement the appropriate revascu-
larization strategy at PCI centres without on-site surgery, and
patients for whom decision-making was complex were discussed
in inter-disciplinary discussion meetings and included decisions
on hybrid intervention. Indications for revascularization, timing of
surgery and procedural aspects followed contemporary guidelines
and successive updates, especially with regard to the type of
revascularization and graft material.
Surgical technique
CPB was conducted with non-pulsatile ﬂow and mild hypothermia
(30–32°C), and the systemic perfusion pressure was electively
Table 2: Definition of outcome end-points
In-hospital mortality Death occurring from index surgery to
discharge or 30 days, whichever is longer
Inotropic support Use of one or more inotropic drugs, for any
length of time
Mechanical support Use of intra-aortic balloon pump or
ventricular (left, right or both) assistance
(roller pumps, centrifugal pumps or
extracorporeal membrane oxygenation) or
both
Cerebrovascular
accident (CVA)
Any neurological deficit of abrupt onset
caused by disturbance in blood supply to
the brain, lasting less (transient ischaemic
attack) or more than 24 h (stroke)
Mediastinitis At least one of the following: (i) an organism
isolated from the culture of mediastinal
tissue or fluid; (ii) evidence of mediastinitis
seen during operation; (iii) one of the
following conditions: chest pain, sternal
instability or fever (>38°C), in combination
with purulent discharge from the
mediastinum that requires surgical
intervention
Myocardial infarction At least one of the following: (i) CK-MB (or
CK if MB not available) ≥ 5 times the
upper limit of normal; (ii) development of
new Q-waves in two or more contiguous
ECG leads
Acute kidney injury
(AKI)
From the acute kidney injury network—
serum creatinine criteria—which
differentiates AKI into three stages: Stage
(1) increase in serum creatinine of 0.3 mg/dl
or increase to 150–200% from baseline;
Stage (2) increase in serum creatinine to
>200–300% from baseline; Stage (3) serum
creatinine increase to >300% from
baseline, serum creatinine 4.0 mg/dl, with
acute increase of 0.5 mg/dl or any dialysis.
Respiratory failure Indicate whether the patient had pulmonary
insufficiency requiring postoperative
ventilator support for >48 h or
tracheostomy, or both
Atrial arrhythmias New atrial fibrillation/flutter requiring
treatment
Prolonged hospital stay Days from index surgery to discharge >14
days
Table 3: Preoperative patient cohort characteristics and
operative data
Study
population
(n = 8515)a
Age (years) 61.9 ± 9.5
Body mass index (kg/m2) 26.2 ± 3.1
Female 1053 (12.4%)
Hypertension 5448 (64.0%)
Diabetes mellitus 2243 (26.3%)
Recent smoking 918 (10.8%)
Peripheral vascular disease 816 (9.6%)
Cerebrovascular disease 661 (7.8%)
Baseline serum creatinine (mg/dl) 1.0 ± 0.6
Renal impairment
On dialysis (regardless of serum creatinine level) 68 (0.8%)
Moderately impaired (CC: 50–85 ml/min) 5296 (62.2%)
Severely impaired (CC: <50 ml/min) off dialysis 1456 (17.1%)
Chronic pulmonary disease 262 (3.1%)
Cardiomegaly 857 (10.1%)
Previous myocardial infarction 4617 (54.2%)
Recent myocardial infarction 791 (9.3%)
Unstable angina 617 (7.2%)
Angina class III/IV, CCS 2843 (33.4%)
Previous cardiac surgery 110 (1.3%)
Previous PCI 612 (7.2%)
Left main disease 1998 (23.5%)
Non-elective surgery 361 (4.3%)
LV ejection fraction (%)
>60 5444 (63.9%)
40–60 2142 (25.2%)
30–39 684 (8.0%)
<30 245 (2.9%)
Extent of vessel disease
1–2 vessel 2003 (23.5%)
3 vessel 6512 (76.5%)
Operative data
No. of distal anastomoses per patient
Arterial 1.24 ± 0.45
Venous 1.51 ± 0.80
Total 2.76 ± 0.79
LITA use 8462 (99.4%)
RITA use 1981 (23.3%)
BITA use 1969 (23.1%)
Coronary endarterectomy 362 (4.3%)
CPB (min) 58.2 ± 20.7
Aortic cross-clamp time/patient (min)b 7.0 ± 5.2
Aortic cross-clamp time/no. of periods of
cross-clamping (min)b
2.6 ± 2.1
BITA: bilateral internal thoracic artery; CC: creatinine clearance; CCS:
Canadian Cardiovascular Society; CPB: cardiopulmonary bypass; LITA:
left internal thoracic artery; LV: left ventricle; PCI: percutaneous
coronary intervention; RITA: right internal thoracic artery; SD: standard
deviation.
aValues are mean ± SD or n (%).
bPopulation: 913 patients in whom the aorta was cross-clamped at least
once.
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maintained at 55–65 mmHg. A left ventricular vent was always
used, introduced through the right superior pulmonary vein and
left atrium. Topical cooling was not used routinely.
The method predominantly used for the construction of the
distal anastomoses was hypothermic ventricular ﬁbrillation. In the
majority of the patients (n = 7480; 89.3%) the aorta was not cross-
clamped at any time. In the remaining patients, the aorta was
cross-clamped at least once, mostly in the ﬁrst 10 years of this
series, with the only purpose of obtaining a drier ﬁeld for a better
exposure of the anastomotic and/or endarterectomy site. In
recent years, aortic cross-clamping was not used in more than
98% of the patients (Fig. 1).
The empty beating heart method, without ﬁbrillation, was fre-
quently used in combination with ventricular ﬁbrillation. Initially
in this experience, a brief application of a direct electrical current
was used to initiate ventricular ﬁbrillation, but after a few years,
grafting was initiated with the heart beating and ventricular ﬁbril-
lation occurred spontaneously in about two thirds of the patients,
as the heart cooled down or with manipulation.
Generally, the anastomoses to the right coronary artery or its
branches on the inferior surface of the heart were constructed ﬁrst,
followed by the anastomoses to the branches of the circumﬂex
system. Bypasses to the anterior descending artery and its diagonal
branches were performed last. However, in the cases with ongoing
ischaemia, the coronary artery branch likely to be involved was
grafted ﬁrst, immediately followed by the respective proximal
anastomosis.
Control of the residual and/or collateral blood ﬂow was
obtained with the use of coronary occluders and/or a soft jet of
carbon dioxide, or, rarely, with intravascular shunts. Occasionally,
we would also slow down the pump ﬂow transiently or, ultimately,
cross-clamp the aorta.
Proximal anastomoses were performed last with a single period
of side-clamping of the ascending aorta. When signiﬁcant athero-
sclerotic disease of the ascending aorta was present, as assessed
by visual inspection and palpation of the site of proximal vein
graft anastomoses (if they had not been identiﬁed preoperatively),
side-clamping was not used and the proximal anastomoses were
performed as an open method during short periods of very low
pump ﬂow, as described in detail in a previous report [4].
A bloodless prime was used in more than 95% of the cases,
whenever the preoperative haematocrit was greater than 35%,
and blood was not administered unless that parameter fell below
20–25% during CPB. Collected mediastinal blood shed during the
ﬁrst 6 postoperative hours was reinfused.
Statistical analysis
Categorical variables are reported as frequency and percentage
and continuous variables as mean ± standard deviation or median
(interquartile range), as appropriate.
More than 50 preoperative and operative patient variables
were available in the database, of which 23 potential risk factors
were chosen, based on univariate screening, clinical knowledge
and previous research. The risk factors selected for analysis are
listed and deﬁned in Table 1.
The entire database was initially used to develop the predictive
logistic models. Univariate screening of all model eligible risk
factors was performed using unpaired Student’s t-test or the Mann–
Whitney U-test for numeric variables, and the χ2 test or Fisher’s
exact test for categorical variables. Variables with a P-value of <0.2
by univariate analysis were used for further analysis.
A multivariate stepwise logistic regression analysis was then per-
formed for each of ﬁve dependent groups: in-hospital mortality
(A); postoperative major morbidity complications: cerebrovascular
accident (B), AKI (C), mediastinitis (D); and prolonged hospital stay
(E), as deﬁned in Table 2.
Because of the relatively small effective sample size of some
events (mediastinitis), a P-value of less than 0.1 was selected for
variable retention in the ﬁnal regression model. Bootstrap analysis
was used in combination with logistic regression analysis to select
the ﬁnal set of risk factors included in the model. In the bootstrap
procedure, 200 samples of 8515 patients (the same number of
observations as the original database) were sampled with replace-
ment. A stepwise logistic regression analysis was applied to every
bootstrap sample. If the predictors occurred in more than 50% of
the bootstrap models, they were judged to be reliable and were
retained in the ﬁnal model.
The risk-prediction model was validated internally by randomly
drawing 200 samples, each containing 100% of the total number
of subjects. The risk-prediction model was applied to each sample
to calculate an individual sample area under the receiver operat-
ing characteristic (ROC) curve and then the mean and standard
error of the mean, with 95% conﬁdence intervals (95% CIs), for all
200 ROC values.
Data were analysed using IBM SPSS Statistics for Windows,
Version 20.0. software (IBM Corp., Armonk, NY, USA).
RESULTS
Postoperative outcomes are presented in Table 4. The overall
in-hospital mortality rate was 0.72% (n = 61). The interval between
surgery and death ranged from 1 to 127 days [median: 6; inter-
quartile range (IQR): 14], and ten of the deaths (16.4%) occurred
beyond 30 days. The cause of death was identiﬁed for 60 of the 61
deaths. Of these, 38 (62.3%) were attributed to heart failure, i.e. to
cardiac cause, 9 (14.8%) to neurological causes, 5 (8.2%) to
Figure 1: Percentage of patients undergoing isolated CABG without and with
periods of aortic cross-clamping, per year. CABG: coronary artery bypass
grafting.
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haemorrhage, 3 (4.9%) to dysrhythmia and 3 (4.9%) to respiratory
failure, pulmonary embolism and aortic dissection, one each. One
cause of death remained unknown.
Five hundred and sixty-two patients (6.6%) required inotropic
support but for longer than 24 h in only 2.0%. In addition, mechan-
ical support (intra-aortic balloon pump, extracorporeal membrane
oxygenation and/or other methods) was used in 64 patients (0.8%).
Two hundred and twenty-three patients (2.6%) had a cerebrovascu-
lar accident (CVA) (stroke or TIA), with recovery in about half. Two
hundred and twelve patients (2.5%) had electrocardiogram (ECG)
and/or biochemical criteria of perioperative myocardial infarction.
The incidence rate of AKI was 18.9% (78.8% Stage 1, 15.9%
Stage 2 and 5.3% Stage 3), but new renal replacement therapy was
required in only 60 patients (0.7%). Atrial arrhythmias, the major-
ity being atrial ﬁbrillation, occurred in 1924 patients (22.6%).
One hundred and seventy patients (2.0%) required reoperation
because of haemorrhage and/or cardiac tamponade, and 112
patients (1.3%) were reoperated for sternal wound complications,
including 69 (0.8%) with the diagnosis of mediastinitis.
The mean hospital stay was 7.2 ± 5.7 days (median = 7 days) and,
in general, patients were discharged to their home. Two hundred
and ﬁfteen patients (2.5%) had a prolonged hospital stay (>14 days).
Risk factors for increased mortality and major
morbidity
The results of the logistic regression risk models for in-hospital mortal-
ity, for postoperative major morbidity complications (cerebrovascular
accident, AKI and mediastinitis) and for prolonged hospital stay are
summarized in Table 5. Age, LV dysfunction, non-elective surgery, pre-
vious cardiac surgery, peripheral vascular disease and CPB time were
independent risk factors for mortality and major morbidity. In add-
ition, female sex, non-elective surgery, known cerebrovascular disease
and number of episodes of aortic cross-clamping were risk factors for
postoperative stroke; recent smoking, bilateral internal thoracic artery
(BITA) use, angina CCS Class III or IV and cardiomegaly for mediastini-
tis; abnormal creatinine clearance for AKI; and BITA use, peripheral
vascular disease, chronic pulmonary disease and angina CCS Class III
or IV for prolonged hospital stay. The risk model performance metrics
are indicated in Table 6.
DISCUSSION
Non-cardioplegic techniques were used in the earliest days of cor-
onary surgery, but most surgeons now use one of several forms of
cardioplegia as an adjunct to CPB during coronary artery revascu-
larization. There is no doubt that cardioplegia affords good pro-
tection of the myocardium, as demonstrated unequivocally by an
endless number of reports dealing with its numerous variations.
However, this does not mean that non-cardioplegic methods,
which are still used by many, result in lesser protection. We and
others have demonstrated the safety and efficacy of these methods
in primary and reoperative CABG, as well in higher risk patients
[1, 5–7]. In fact, a recent meta-analysis, based on 13 studies, of
which eight were randomized prospective trials, showed that
intermittent ischaemic arrest provides equal or better protection
in comparison with cardioplegic techniques [8]. Other studies that
compared cardioplegic techniques with the on-pump beating
heart technique showed that the latter provides better myocardial
protection and early results, particularly in the setting of acute
myocardial infarction [9, 10].
Among the advantages claimed for the non-cardioplegic methods
are the more expeditious surgery, less haemodilution resulting in
lesser usage of blood and blood products and, most importantly, the
continuous ‘natural’ irrigation of the myocardium throughout the
entire surgery (when aortic cross-clamping is not used). On the other
hand, because of the constantly perfused myocardium, a technically
more demanding distal anastomosis could be expected. In fact, re-
traction of the heart for exposure of lateral and posterior wall coron-
ary arteries may be more difﬁcult and a more bloody operative ﬁeld
is predictable, although not signiﬁcantly different from that seen with
the continuous blood cardioplegic techniques. But, in our experi-
ence, the empty heart permits adequate manipulation and easy
access to all segments of the arteries to be bypassed.
Mortality is the most commonly studied outcome and is one of
the indicators most frequently used to assess efﬁciency and
quality of health care provided to patients submitted to all kinds
of cardiac procedures, including myocardial revascularization. In
this series, the global in-hospital mortality rate was 0.72%. This
rate is generally lower than those published in the international lit-
erature for identical patient groups and using the same deﬁnition
for reporting this event [11, 12]. However, although in-hospital
mortality represents one of the most widely reported metrics to
assess death after CABG, this is a short time period for the early
risk, which extends up to 2–3 months [13].
Next to operative mortality, cerebrovascular accidents, especial-
ly stroke, are one of the most dreaded complications following
CABG, not only for the devastating consequences to the patients
and their families, but also for the vastly increased cost of
Table 4: Perioperative outcomes
Study
population
(n = 8515)a
In-hospital mortality 61 (0.7%)
Perioperative morbidity
Inotropic support 562 (6.6%)
<12 h 196 (2.3%)
12–24 h 193 (2.3%)
>24 h 173 (2.0%)
Mechanical support 64 (0.8%)
IABP 14 (0.2%)
VAD 34 (0.4%)
IABP plus VAD 16 (0.2%)
Cerebrovascular accident 223 (2.6%)
Mediastinitis 69 (0.8%)
Myocardial infarction 212 (2.5%)
Acute kidney injuryb
No AKI 6851 (81.1%)
AKI stage 1 1258 (78.8%)
AKI stage 2 253 (15.9%)
AKI stage 3 85 (5.3%)
Respiratory failure 45 (0.5%)
Reoperation for bleeding/cardiac tamponade 170 (2.0%)
Atrial arrhythmias 1924 (22.6%)
Length of hospital stay (alive), days (mean ± SD) 7.2 ± 5.7
Prolonged hospital stay (>14 days) 215 (2.5%)
IABP: intra-aortic balloon pump; VAD: ventricular assist device; SD:
standard deviation.
aValues are expressed as n (%) or mean ± SD.
bn = 8447 (68 patients on preoperative dialysis were excluded).
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hospitalization and subsequent care. Additionally, it partially
offsets the beneﬁts of CABG over other forms of treatment, i.e.
medical therapy and percutaneous revascularization procedures.
In this series, the incidence rate of cerebrovascular accident was
2.6%, which is comparable with the incidence rates for isolated
CABG coming from some studies [14, 15] but higher than the 1.6%
reported by others [16, 17]. Most episodes were, however, transi-
ent, with recovery in50% of the cases.
There is a consensus that the principal source of cerebral
macroemboli is the ascending aorta. By potentially reducing the
embolic consequences of manipulation of the aorta, ﬁbrillatory
arrest without aortic cross-clamping may decrease the incidence
of cerebrovascular accidents in CABG. In a previously published
study, we found that the number of periods of aortic cross-
clamping was an independent risk factor for CVA (odds ratio of 1.3
per each episode of cross-clamping) [16]. Because of our early
awareness of this fact, reinforced by the results of that study, we
have progressively reduced the number of periods of cross-
clamping, which have been consistently avoided since 2003 in
more than 98% of the patients (Fig. 1). This is, probably, one of the
causes of the decreasing incidence of CVA over time (Fig. 2).
Despite improvements in surgical, anaesthetic and periopera-
tive care for cardiac surgery patients, AKI still remains a common
postoperative complication [17]. The incidence of AKI depends
critically on the manner in which it is deﬁned. In this study, we
Table 5: Logistic regression risk models for in-hospital mortality (A); postoperative major morbidity complications:
cerebrovascular accident (B), acute kidney injury (C), mediastinitis (D) and for prolonged hospital stay (E)
Model Risk factor Coefficient P-value Odds ratio 95% CI (OR)
A Age (per 1 year increase) 0.051 0.001 1.053 1.021 1.086
LV dysfunction 0.881 0.004 2.414 1.324 4.400
Non-elective surgery 1.252 0.001 3.496 1.686 7.250
Previous cardiac surgery 1.687 0.002 5.405 1.865 15.666
Peripheral vascular disease 1.295 <0.001 3.651 2.126 6.269
CPB time (per 1 min increase) 0.009 0.004 1.009 1.003 1.015
Constant −9.350
B Age (per 1 year increase) 0.032 <0.001 1.033 1.016 1.049
LV dysfunction 0.460 0.016 1.584 1.088 2.307
No. periods of aortic cross-clamping 0.238 0.042 1.268 1.008 1.595
CPB time (per 1 min increase) 0.005 0.022 1.005 1.001 1.010
Non-elective surgery 0.550 0.037 1.733 1.033 2.907
Female sex 0.556 0.002 1.743 1.234 2.462
Cerebrovascular disease 1.020 <0.001 2.774 1.955 3.936
Constant −6.356
C Recent smoking 0.663 0.026 1.940 1.082 3.478
BITA use 1.471 <0.001 4.356 2.679 7.081
Angina CCS Class III or IV 0.538 0.029 1.712 1.056 2.776
Cardiomegaly 1.031 0.001 2.805 1.565 5.025
Constant −5.837
D Peripheral vascular disease 0.227 0.026 1.255 1.027 1.533
Cerebrovascular disease 0.303 0.008 1.353 1.082 1.693
Cardiomegaly 0.325 0.001 1.384 1.141 1.679
CPB time (per 1 min increase) 0.013 <0.001 1.013 1.009 1.017
Angina CCS Class III or IV 0.174 0.012 1.190 1.040 1.362
Non-elective surgery 0.733 <0.001 2.082 1.544 2.808
Creatinine clearance groups_MDRD <0.001
Creatinine clearance group MDRD1 −0.054 0.472 0.948 0.818 1.097
Creatinine clearance group MDRD2 0.210 0.020 1.233 1.033 1.472
Creatinine clearance group MDRD3 0.836 <0.001 2.308 1.548 3.441
Constant −2.411
E Age (per 1 year increase) 0.029 0.001 1.030 1.012 1.047
LV dysfunction 0.738 <0.001 2.093 1.515 2.891
No. of periods of aortic cross-clamping 0.353 <0.001 1.423 1.179 1.717
CPB time (per 1 min increase) 0.005 0.029 1.005 1.001 1.010
BITA use 0.791 <0.001 2.206 1.559 3.121
Peripheral vascular disease 0.573 0.001 1.774 1.275 2.468
Chronic pulmonary disease 0.839 0.002 2.315 1.379 3.886
Angina CCS Class III or IV 0.394 0.003 1.483 1.141 1.927
Constant −6.343
Table 6: Risk model performance metrics
AUC (95% CI) H-L
test
H-L test
P-value
Final mortality model 0.754 (0.688, 0.819) 7.530 0.481
Final CVA model 0.667 (0.629, 0.705) 3.962 0.861
Final mediastinitis model 0.741 (0.681, 0.801) 2.072 0.558
Final AKI model 0.602 (0.584, 0.619) 19.529 0.062
Final PLOS model 0.680 (0.643, 0.717) 4.768 0.782
AKI: acute kidney injury; CVA: cerebrovascular accident; H-L: Hosmer–
Lemeshow; PLOS: prolonged hospital stay.
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have used the strict Acute Kidney Injury Network criteria, which is
widely accepted, and its utility in predicting the prognostic impact
of AKI on in-hospital and long-term mortality has been evaluated
in the cardiac surgical population [17, 18]. In our series, the inci-
dence rate of AKI was only 19%. Of these, 79% had Stage I injury,
which is a mild form and does not require renal replacement
therapy. These ﬁndings are consistent with those of other studies,
such as that by Li et al. who reported an incidence rate of AKI fol-
lowing elective CABG of 19.8% [18].
Mediastinitis is a severe complication of CABG and is associated
with increased morbidity, mortality and cost. The incidence rate
of this complication is usually reported between 0.4 and 4%, and
was 0.8% (69 patients) in this series, a value that falls among the
lowest commonly reported [19, 20], which may be related to faster
surgery and less haemodilatation.
Adequate myocardial protection is an important issue regarding
the safety and efﬁcacy of these methods, but is difﬁcult to evalu-
ate. In this study, the incidence of use of inotropic (6.6%) or mech-
anical support (0.8%) and of myocardial infarction (2.5%) was low
and compare favourably with those reported by others. We
believe that, although not speciﬁc, these results constitute good
clinical indicators of the safety and efﬁcacy of non-cardioplegic
methods in terms of myocardial protection. Finally, the low inci-
dence rates of other causes of morbidity, as well as the mean dur-
ation of hospital stay (7.2 ± 5.7 days), also constitute good clinical
indicators for a relatively smooth perioperative period and, pre-
sumably, are also an index of good myocardial protection.
In this study, we identiﬁed and conﬁrmed the usual risk factors for
mortality and major morbidity including age, LV dysfunction, non-
elective surgery, previous cardiac surgery, peripheral vascular disease
and CPB time. Not surprisingly, recent smoking and use of BITAwere
independent predictors of mediastinitis; abnormal creatinine clear-
ance of AKI; and peripheral vascular disease, chronic pulmonary
disease and angina CCS Class III or IV of prolonged hospital stay.
BITA use also came up as a predictor of prolonged hospitalization,
but this may have been inﬂuenced by its impact in the incidence of
mediastinitis. Knowledge of the inﬂuence of these risk factors, most
of which can be modulated, may help improve the results.
Limitations of the study
We recognise some limitations in this study, which may affect its
conclusions. Although in-hospital mortality represents one of the
most widely reported metrics to assess results after CABG, this is
too short an interval for the evaluation of early results; conse-
quently, the results reported in this work could be underesti-
mated. In addition, the deﬁnition used to report the occurrence
of MI is too narrow for accurate diagnosis of this event.
The impact of this technique on the quality of the anastomoses
evaluated by long-term mortality, myocardial infarction and need
for reintervention remains unknown in this series of patients due
to the lack of angiographic follow-up.
Because of the historical component of this study, no inter-
national risk scoring system was used (the EuroSCORE was intro-
duced only in 1999). However, it is our feeling, based on recent
calculations using EuroSCORE II, that our patients in this unse-
lected population have an average risk.
CONCLUSION
The results in this series demonstrate that non-cardioplegic
methods afford good perioperative results, with low mortality and
morbidity, in patients undergoing isolated CABG with CPB. They
are simple and expeditious and remain very useful alternative
techniques of myocardial preservation, and should be known to
every surgeon who performs coronary surgery. In our experience,
they are superior to cardioplegia. Our belief is so strong that in
composite procedures, especially in associated valve surgery, the
myocardial revascularization component is performed without
cross-clamping, either before or after the valve surgery, which is
performed under cardioplegia.
Conﬂict of interest: none declared.
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APPENDIX. CONFERENCE DISCUSSION
Scan to your mobile or go to
http://www.oxfordjournals.org/page/6153/1
to search for the presentation on the EACTS library
Dr P. Sergeant (Leuven, Belgium): The authors present a study of a very large
cohort of patients, 8515, covering a 20-year interval. The surgical procedure is
CABG performed with CPB and without cardioplegia, most frequently using ven-
tricular ﬁbrillation. The authors present very respectable low hospital mortality.
The study population has an average age of 62 years and a very low female/
male gender ratio. No international risk scoring system has been used in this
manuscript, with all their limitations, and we’re not going to discuss the limita-
tions of the scoring systems, but it does not really allow for comparisons of risk
proﬁle. So based on a crude analysis that I was able to perform based on the
data submitted, I have the impression it’s a rather low-risk proﬁle that is identi-
ﬁed, with an average age of 61 years as just one example of one variable.
Arterial grafting using both internal artery grafts was very extensive, and I
have to congratulate the authors for that, with up to 23% of the patients having
both internal arteries constructed for grafting.
We identiﬁed in the manuscript a high use of 6.6% of inotropic support, not
abnormal for this kind of surgical approach, even in the presence of short per-
fusion times at moderate hypothermia.
We were somewhat disappointed by the 5% of patients excluded due to
missing ﬁles. I know some of these were also off-pump patients, but that’s the
only thing I could get out of the manuscript ‘excluded due to missing ﬁles’ in
this prospective study. It’s a prospective study and at the same time we’re
missing 5%.
In fact, we’re also disappointed by the total absence of data after discharge
from the primary hospital. As written down by Manuel in the manuscript, there
is, of course, a whole lack of information of the early risk. So no data were
reported even about the patients discharged home or to another hospital. So I’m
not convinced that this manuscript presents early results. It doesn’t even present
in-hospital mortality or the whole time interval of the hospital mortality.
We have identiﬁed in these, as stated repeatedly, the low in-hospital mortal-
ity for as far as it is cited, but also the, very honestly, extremely high stroke rate
of 2.6% for a rather low stroke risk population. I mean, there are very few
patients in cardiac massage or in catastrophic situations.
I very much enjoyed the graphic that has been presented here also depicting
the reduction over time of aortic clamping. I must say in my ﬁrst reading of
the manuscript I missed that the graphic showed aortic cross-clamping, so I
thought it was clamping. So an in-depth reading of the manuscript identiﬁed
that I had misread this. But that was well depicted here, that the graphic con-
cerned also the total cross-clamping, so not the side clamping. So it’s deﬁnitely
no depiction of no-touch aortic technique and that has to be related to the
2.6% stroke risk.
I understand very well that stroke is a multifactorial issue and that total aortic
clamping is just one element to reduce the stroke rate.
It is clear that several other elements play a role as there are cannulation,
decannulation, side clamping of the aorta, the sandblasting effect of the perfu-
sion on the walls, possibly low mean pressures during extracorporeal circula-
tion, and the anticoagulation regimen after surgery. So there are whole
numbers of elements that induce stroke.
I therefore have one single question to Prof Antunes: Do you believe that
there is a future for surgical therapy when we have 2.6% stroke rate, when pos-
sible alternative either surgical techniques or interventional strategies can avoid
this high stroke rate?
Dr Antunes: The ﬁrst point that you raised is the rather low-risk proﬁle. We
do have that information in the database, but we didn’t put it in here because
we didn’t think that it was really important. We don’t want to compare our
series with some others. It was rather an indication of the technique we used. It
is, however, a totally unselected population because that includes 100% of the
patients operated on during that period, there are no exclusions.
You made a reference of some missing ﬁles. There are no missing ﬁles. But
when we reviewed the data, we found that the data was not complete for all
patients. So, we decided not to include every patient that missed one of the
data that should have been inserted. We thought with a greater than 8000
population that was a sure sample for doing this analysis.
In Portugal, virtually no patients are discharged to other wards or to other
hospitals; the patients are discharged home only when they are well. That’s why
some patients died in hospital after up to 127 days. So this is total perioperative
events that we are reporting. And we are quite sure that, again, if one patient
did not have that information, we did not include it in the series.
The stroke rate is indeed one worry of ours. I don’t want to compare this with
off-clamp coronary surgery which was speciﬁcally designed to avoid the stroke.
I must already say, however, that this includes minor and major stroke. That is,
all types of neurological events that we could identify clinically. Most of the
patients, of course, recovered from it.
Now, if I believe that this is a technique still valid today, I can only say that we
took the care 20 years ago, of comparing our results, my personal results, with
this technique in the ﬁrst 100 patients with those of 100 patients before, and at
that time it was better. And we still believe that 0.7% mortality for a total popu-
lation of 8500 patients can stand comparison with any other method that are
used, but I don’t want to play the game, this is not a competition.
Dr J. Puskas (New York, New York, USA): Just following on Dr Sergeant’s
comment regarding stroke, he identiﬁed numerous of the many factors that go
into stroke in a perioperative period. He did not touch upon something that
struck me about your technique, and that is, the introduction of a vent into the
left atrium in a beating heart. If I heard your comments correctly, 90% of these
patients did not have a clamp on the aorta.
Dr Antunes: Not a cross-clamp, that is correct.
Dr Puskas: Not a cross-clamp. And many were beating, some ﬁbrillated, but
you did not intentionally use an electric ﬁbrillator to create ﬁbrillation before
introducing a vent into the left side of the atrium. I personally am very nervous
about any violation of the left side of the heart in a situation where the heart
can beat. Because even though the aorta is pressurized by the heart-lung
machine, a little AI will ﬁll the ventricle and it can eject, and it can eject air that
one can inadvertently introduce into the left atrium. So I wonder if that might
explain your relatively higher stroke rate and yet a relatively low mortality.
Perhaps the strokes were due to air and the patients recovered and didn’t die.
Dr Antunes: Well, that’s a possibility, but I don’t think so because the heart is
ﬁlled up when we introduce the LV vent and that’s done in the same way as we
do for any other procedures on the left side of the heart, namely, aortic valve
replacement.
We are careful that we don’t introduce the vent without making sure that the
heart is full, so that the air doesn’t go in but rather comes out immediately on
that. But again, it’s a consideration.
Of course, we acknowledge some of the ﬂaws in the paper identiﬁed in here
and, if the paper passes the ﬁrst evaluation for acceptance in the Journal, we
will introduce some of the data that was requested by the discussants.
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